Gilead Sciences (GILD) Non-Current Deferred Tax Liability (2012 - 2026)

Gilead Sciences has reported Non-Current Deferred Tax Liability for 11 years, with the latest figure at $392.0 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Deferred Tax Liability fell 44.71% year-over-year to $392.0 million; the trailing twelve-month figure through Mar 2026 stood at $392.0 million (down 44.71% YoY), and the FY2025 full-year result was $402.0 million, down 44.48% from the prior year.
• Non-Current Deferred Tax Liability for Q1 2026 stood at $392.0 million, down from $402.0 million in the prior quarter.
• The five-year high for Non-Current Deferred Tax Liability was $3.7 billion in Q1 2022, with the low at $392.0 million in Q1 2026.
• Historically, Non-Current Deferred Tax Liability has averaged $1.6 billion across 5 years, with a median of $933.0 million in 2024.
• Annual changes were most pronounced in 2022 — Non-Current Deferred Tax Liability dropped 17.41% — and 2024, when it plunged 61.14%.
• Gilead Sciences' Non-Current Deferred Tax Liability stood at $2.7 billion in 2022, then plunged by 40.59% to $1.6 billion in 2023, then tumbled by 54.41% to $724.0 million in 2024, then sank by 44.48% to $402.0 million in 2025, then slipped by 2.49% to $392.0 million in 2026.
• The last three Non-Current Deferred Tax Liability figures came in at $392.0 million (Q1 2026), $402.0 million (Q4 2025), and $597.0 million (Q3 2025), per Business Quant data.